Tag: Safe

Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...

Apps are offering solutions for dating situations gone wrong, providing features such as fake calls and discreet messaging to ensure ...

IT contractor CGI Federal has reported a data breach that exposed personal information of about 6,000 employees, causing potential financial ...

The SEC has adopted final rules to enhance disclosure requirements for SPACs, aiming to protect investors and align regulations with ...

SpaceX's Elon Musk confirms that the Starship rocket is set for a test flight in March, a crucial milestone in ...

Amazon's kid-friendly tablets offer huge discounts and comprehensive parental controls, making them a safe and suitable choice for children. With ...

Italy's government is reviewing Vitol's plan to acquire oil refiner Saras under "golden power" rules, seeking commitments on job security, ...

Beacon has completed its acquisition of Metro Sealant & Waterproofing, expanding its services in the waterproofing sector. This aligns with ...

AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...

Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...